Pardeep Nijhawan Medicine Professional Corp, Chief Executive Officer, 10% Owner at Edesa Biotech, Inc. (EDSA), bought 3,000 shares at $2.98 ($9K) on 2020-05-26, disclosed to the SEC on 2020-05-28.
Open-market purchase of $9k EDSA by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| EDSA | BUY | 2021-03-29 | $10K | — | Filing → |
| EDSA | BUY | 2020-03-19 | $7K | — | Filing → |